LAB logo

Standard BioTools (LAB) CAPEX

Annual CAPEX

$2.83 M
-$994.00 K-25.99%

31 December 2023

3-Year Change

-78.66%
LAB annual capital expenditures is down -78.66% over the past 3 years

All-time High

$13.26 M
LAB annual capital expenditures is currently -78.66% below its historical high of $13.26 million

Sector Rank

48.16%
LAB annual capital expenditures is higher than 48.16% of companies in Healthcare sector
Annual FCF-$46.12 M
LAB annual free cash flow is -$46.12 million
Annual CFO-$43.29 M
LAB annual cash flow from operations is -$43.29 million
Annual CFI$20.24 M
LAB annual cash flow from investing activities is $20.24 million
Annual CFF-$6.81 M
LAB annual cash flow from financing activities is -$6.81 million

LAB CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

$2.25 M
+$318.00 K+16.42%

30 September 2024

1-Year Change

+2791.03%
LAB quarterly capital expenditures is up +2791.03% year-on-year

3-Year Change

+387.04%
LAB quarterly capital expenditures is up +387.04% over the past 3 years

All-time High

$10.71 M
LAB quarterly capital expenditures is currently -78.94% below its historical high of $10.71 million

Sector Rank

63.97%
LAB quarterly capital expenditures is higher than 63.97% of companies in Healthcare sector
Quarterly FCF-$30.12 M
LAB quarterly free cash flow is -$30.12 million
Quarterly CFO-$27.87 M
LAB quarterly cash flow from operations is -$27.87 million
Quarterly CFI-$30.88 M
LAB quarterly cash flow from investing activities is -$30.88 million
Quarterly CFF-$2000.00
LAB quarterly cash flow from financing activities is -$2000.00

LAB Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

$5.05 M
+$1.35 M+36.48%

30 September 2024

1-Year Change

+78.42%
LAB TTM capital expenditures is up +78.42% year-on-year

3-Year Change

-61.92%
LAB TTM capital expenditures is down -61.92% over the past 3 years

All-time High

$23.51 M
LAB TTM capital expenditures is currently -78.51% below its historical high of $23.51 million

Sector Rank

53.68%
LAB TTM capital expenditures is higher than 53.68% of companies in Healthcare sector
TTM FCF-$148.51 M
LAB TTM free cash flow is -$148.51 million
TTM CFO-$143.46 M
LAB TTM cash flow from operations is -$143.46 million
TTM CFI$324.33 M
LAB TTM cash flow from investing activities is $324.33 million
TTM CFF-$49.10 M
LAB TTM cash flow from financing activities is -$49.10 million

LAB TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LAB CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+2791.0%+78.4%
3 y3 years-78.7%+387.0%-61.9%
5 y5 years+11.8%+351.0%+99.6%

LAB CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-78.7%at lowat high+2791.0%-61.9%+94.1%
5 y5 years-78.7%+11.8%-78.9%+2791.0%-78.5%+101.2%
alltimeall time-78.7%+661.0%-78.9%>+9999.0%-78.5%+1307.0%

Standard BioTools CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.25 M(+16.4%)
$5.05 M(+36.5%)
June 2024
-
$1.94 M(+148.0%)
$3.70 M(+42.2%)
Mar 2024
-
$781.00 K(+901.3%)
$2.60 M(-8.1%)
Dec 2023
$2.83 M(-26.0%)
$78.00 K(-91.4%)
$2.83 M(-19.3%)
Sept 2023
-
$905.00 K(+8.0%)
$3.51 M(-9.3%)
June 2023
-
$838.00 K(-17.0%)
$3.87 M(-2.5%)
Mar 2023
-
$1.01 M(+33.8%)
$3.97 M(+3.7%)
Dec 2022
$3.83 M(-71.2%)
$755.00 K(-40.3%)
$3.83 M(+8.3%)
Sept 2022
-
$1.26 M(+34.8%)
$3.53 M(-11.1%)
June 2022
-
$938.00 K(+8.1%)
$3.98 M(-44.9%)
Mar 2022
-
$868.00 K(+87.5%)
$7.21 M(-45.6%)
Dec 2021
$13.26 M(+4.3%)
$463.00 K(-72.9%)
$13.26 M(-43.6%)
Sept 2021
-
$1.71 M(-59.1%)
$23.51 M(+6.2%)
June 2021
-
$4.17 M(-39.7%)
$22.14 M(+19.0%)
Mar 2021
-
$6.92 M(-35.3%)
$18.61 M(+46.3%)
Dec 2020
$12.72 M(+402.4%)
-
-
Dec 2020
-
$10.71 M(+3058.4%)
$12.72 M(+406.7%)
Sept 2020
-
$339.00 K(-47.1%)
$2.51 M(-28.6%)
June 2020
-
$641.00 K(-37.8%)
$3.52 M(+6.7%)
Mar 2020
-
$1.03 M(+106.0%)
$3.29 M(+30.2%)
Dec 2019
$2.53 M(+580.4%)
-
-
Dec 2019
-
$500.00 K(-62.9%)
$2.53 M(+23.4%)
Sept 2019
-
$1.35 M(+221.2%)
$2.05 M(+127.1%)
June 2019
-
$419.00 K(+57.5%)
$903.00 K(+61.0%)
Mar 2019
-
$266.00 K(+1230.0%)
$561.00 K(+50.8%)
Dec 2018
$372.00 K(-77.0%)
$20.00 K(-89.9%)
$372.00 K(-35.9%)
Sept 2018
-
$198.00 K(+157.1%)
$580.00 K(-38.0%)
June 2018
-
$77.00 K(0.0%)
$936.00 K(-6.5%)
Mar 2018
-
$77.00 K(-66.2%)
$1.00 M(-38.1%)
Dec 2017
$1.62 M
$228.00 K(-58.8%)
$1.62 M(-22.4%)
Sept 2017
-
$554.00 K(+290.1%)
$2.08 M(-35.7%)
June 2017
-
$142.00 K(-79.5%)
$3.24 M(-29.8%)
DateAnnualQuarterlyTTM
Mar 2017
-
$692.00 K(-0.3%)
$4.61 M(-8.9%)
Dec 2016
$5.07 M(-52.5%)
$694.00 K(-59.4%)
$5.07 M(-58.8%)
Sept 2016
-
$1.71 M(+12.6%)
$12.31 M(+13.1%)
June 2016
-
$1.52 M(+32.7%)
$10.88 M(+1.1%)
Mar 2016
-
$1.14 M(-85.6%)
$10.77 M(+1.1%)
Dec 2015
$10.65 M(+43.9%)
$7.94 M(+2684.9%)
$10.65 M(+153.7%)
Sept 2015
-
$285.00 K(-79.7%)
$4.20 M(-20.3%)
June 2015
-
$1.40 M(+36.2%)
$5.27 M(-20.4%)
Mar 2015
-
$1.03 M(-30.7%)
$6.62 M(-10.6%)
Dec 2014
$7.40 M(+58.0%)
$1.48 M(+9.4%)
$7.40 M(-7.4%)
Sept 2014
-
$1.36 M(-50.7%)
$8.00 M(+11.2%)
June 2014
-
$2.75 M(+51.7%)
$7.19 M(+23.9%)
Mar 2014
-
$1.81 M(-12.8%)
$5.80 M(+23.8%)
Dec 2013
$4.69 M(+96.6%)
$2.08 M(+279.2%)
$4.69 M(+39.0%)
Sept 2013
-
$548.00 K(-59.8%)
$3.37 M(+5.2%)
June 2013
-
$1.36 M(+95.1%)
$3.21 M(+19.4%)
Mar 2013
-
$698.00 K(-8.5%)
$2.69 M(+12.6%)
Dec 2012
$2.38 M(-35.1%)
$763.00 K(+99.7%)
$2.38 M(-44.6%)
Sept 2012
-
$382.00 K(-54.6%)
$4.30 M(+2.4%)
June 2012
-
$842.00 K(+112.1%)
$4.20 M(+9.0%)
Mar 2012
-
$397.00 K(-85.2%)
$3.85 M(+4.8%)
Dec 2011
$3.68 M(+138.9%)
$2.68 M(+846.6%)
$3.68 M(+161.5%)
Sept 2011
-
$283.00 K(-42.7%)
$1.41 M(-11.8%)
June 2011
-
$494.00 K(+124.5%)
$1.59 M(+13.9%)
Mar 2011
-
$220.00 K(-46.2%)
$1.40 M(-9.0%)
Dec 2010
$1.54 M(+92.6%)
$409.00 K(-13.3%)
$1.54 M(+36.2%)
Sept 2010
-
$472.00 K(+57.9%)
$1.13 M(+71.7%)
June 2010
-
$299.00 K(-16.7%)
$658.00 K(+83.3%)
Mar 2010
-
$359.00 K
$359.00 K
Dec 2009
$799.00 K(-12.2%)
-
-
Dec 2008
$910.00 K(-6.5%)
-
-
Dec 2007
$973.00 K(-66.8%)
-
-
Dec 2006
$2.93 M
-
-

FAQ

  • What is Standard BioTools annual capital expenditures?
  • What is the all time high annual CAPEX for Standard BioTools?
  • What is Standard BioTools quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Standard BioTools?
  • What is Standard BioTools quarterly CAPEX year-on-year change?
  • What is Standard BioTools TTM capital expenditures?
  • What is the all time high TTM CAPEX for Standard BioTools?
  • What is Standard BioTools TTM CAPEX year-on-year change?

What is Standard BioTools annual capital expenditures?

The current annual CAPEX of LAB is $2.83 M

What is the all time high annual CAPEX for Standard BioTools?

Standard BioTools all-time high annual capital expenditures is $13.26 M

What is Standard BioTools quarterly capital expenditures?

The current quarterly CAPEX of LAB is $2.25 M

What is the all time high quarterly CAPEX for Standard BioTools?

Standard BioTools all-time high quarterly capital expenditures is $10.71 M

What is Standard BioTools quarterly CAPEX year-on-year change?

Over the past year, LAB quarterly capital expenditures has changed by +$2.18 M (+2791.03%)

What is Standard BioTools TTM capital expenditures?

The current TTM CAPEX of LAB is $5.05 M

What is the all time high TTM CAPEX for Standard BioTools?

Standard BioTools all-time high TTM capital expenditures is $23.51 M

What is Standard BioTools TTM CAPEX year-on-year change?

Over the past year, LAB TTM capital expenditures has changed by +$2.22 M (+78.42%)